Both HPep1 and HPep6 inhibited LPS-induced TNF-α release in human peripheral blood mononuclear cells (PBMCs) and also decreased serum levels of TNF-α in a mouse model of subclinical endotoxemia, suggesting that these two LPS-binding peptides may have potential as antiseptic therapeutics. Here, TNF is linked to serum lipopolysaccharide activity.